✦ LIBER ✦

Results of cancer and leukemia group B protocol 8935: A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer

Book ID: 122811241
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 126 KB
Volume: 13
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)90256-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

271 Trimodality treatment of surgically

271 Trimodality treatment of surgically staged IIIA (N2) non-small cell lung cancer (NSCLC): Updated analysis of cancer and leukemia group B (CALGB) protocol 8935

✍ Kumar, Parvesh; Herndon, J.; Sugarbaker, D.; Green, M.R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Patterns of disease failure after trimod

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935

✍ Parvesh Kumar; James Herndon II; Mark Langer; Leslie J. Kohman; Anthony D. Elias 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

The impact of sequential trimodality therapy on the pattern of first site disease failure in pathologic Stage IIIA (N2) nonsmall cell lung carcinoma (NSCLC) was analyzed. ## METHODS. Seventy-four eligible patients with histologically documented Stage IIIA (N2) NSCLC underwent sequential trimodali

Patterns of disease failure after trimod

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic Stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Results of Trimodality Therapy in Patien

Results of Trimodality Therapy in Patients With Stage IIIA (N2-Bulky) and Stage IIIB Non–Small-Cell Lung Cancer

✍ Jian Li; Chun-Hua Dai; Li-Chao Yu; Ping Chen; Xiao-Qin Li; Shun-Bing Shi; Jing-R 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

Nodal downstaging predicts survival foll

Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935

✍ Michael T. Jaklitsch; James E. Herndon II; Malcolm M. DeCamp Jr.; William G. Ric 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Phase II trial of 4′-deoxydoxorubicin (D

Phase II trial of 4′-deoxydoxorubicin (DxDx) in non-small cell lung cancer: A cancer and leukemia group B trial

✍ Ringenberg, Q. Scott ;Perry, Michael C. ;Propert, Kathleen J. ;Modeas, Caron ;Hi 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB